Company profile: Toyobo
1.1 - Company Overview
Company description
- Provider of life science products in Japan for research and industrial fields, including KOD DNA Polymerase with proofreading/high elongation for PCR; ReverTra Ace M-MLV reverse transcriptase for efficient cDNA synthesis; MagExtractor kits with magnetic silica beads for nucleic acid extraction; THUNDERBIRD qPCR mix for SYBR Green I; GenNext NGS library prep for Illumina; and one-step RT-PCR Quick Master Mix using Tth DNA polymerase.
Products and services
- KOD DNA Polymerase: Archaeal-derived enzyme from Thermococcus kodakaraensis KOD1 with proofreading activity and high elongation capability, engineered for PCR applications requiring accurate amplification
- THUNDERBIRD qPCR Mix: SYBR Green I-based real-time PCR master mix engineered for high specificity and efficient amplification in SYBR Green I assays
- MagExtractor Kits: Magnetic-bead-based assemblies utilizing silica-coated particles to extract nucleic acids from diverse specimens, facilitating high-throughput workflows and automated processes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Toyobo
Iridia
HQ: United States
Website
- Description: Provider of nanotechnology solutions that embed synthetic DNA molecules into products to deliver authenticity, traceability, and data infusion. Offers a Molecular Avatar Technology platform for supply chain transparency, embedding data directly into materials, enabling personalized information and Web3-enabled utilities for enhanced customer engagement, and art authentication to ensure provenance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iridia company profile →
Nutcracker Therapeutics
HQ: United States
Website
- Description: Provider of mRNA therapeutics and an integrated RNA manufacturing platform: the Nutcracker Manufacturing Unit (NMU) for rapid mRNA production from DNA sequences; GMP-in-a-box to lower costs and cycle times; CodonCracker software to optimize RNA sequences; Nutshell delivery vehicles; an RNA therapeutics pipeline across HPV-driven tumors, T cell lymphoma, and genitourinary tumors; and strategic collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutcracker Therapeutics company profile →
Diagnoplex
HQ: Switzerland
Website
- Description: Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnoplex company profile →
Tavotek Biotherapeutics
HQ: United States
Website
- Description: Provider of therapeutic medicine discovery, development and commercialization, with platforms and programs including TavoSelect phage display to discover diversified human antibody sequences for biologics and diagnostics; TavoPrecise to develop optimized mono- and multi-specific biologics; TavoELITE to address intracellular undruggable targets; and oncology and immunology therapeutics for cancer, inflammatory and allergic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tavotek Biotherapeutics company profile →
GenturaDx
HQ: United States
Website
- Description: Provider of molecular diagnostic solutions focused on making multiplexed molecular testing affordable and practical for any laboratory to perform. Offers the IDbox system and single-use cassette designed to circumvent barriers of cost, automation and performance, facilitating in-house lab testing for actionable results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenturaDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Toyobo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Toyobo
2.2 - Growth funds investing in similar companies to Toyobo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Toyobo
4.2 - Public trading comparable groups for Toyobo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →